|
⚲
|
| Keyboard |
| Taveras Arthur
✚
|
|
|---|---|
| CIK # | 0001830901 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001830901] | |
| 4 | [0001830901] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| X4 Pharmaceuticals Inc | |
| Taveras Arthur |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2024-10-07 | Sell | 76,920 | $0.56 | 43,075 |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2024-10-04 | Grant | 230,645 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2024-03-11 | Sell | 14,235 | $0.88 | 12,527 |
|
X4 Pharmaceuticals Inc XFOR
Stock Appreciation Right · derivative
|
2024-02-13 | Grant | 428,248 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2024-02-12 | Sell | 787 | $1.01 | 795 |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2023-11-01 | Sell | 67,695 | $0.73 | 49,417 |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2023-10-31 | Grant | 230,645 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2023-03-10 | Sell | 16,806 | $0.84 | 14,117 |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2023-02-13 | Sell | 928 | $0.93 | 863 |
|
X4 Pharmaceuticals Inc XFOR
Stock Appreciation Right · derivative
|
2022-11-07 | Grant | 1,000,000 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2022-03-01 | Grant | 97,000 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2022-02-11 | Tax withheld | 928 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2021-03-24 | Grant | 8,035 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2020-11-30 | Grant | 121,150 | $6.60 | 799,590 |